A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer
1. 系统已在2026-01-11 17:34:01对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.clbc.2024.11.019
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1526820924003331
其他信息:
出版社: Elsevier BV
作者: Sailaja Kamaraju; Amy M. Fowler; Sergey Tarima; Lubna N. Chaudhary; Mark E. Burkard; Thomas Giever; Yee C. Cheng; Amanda Parkes; Carol A. Lange; Michele Pipp-Dahm; Robert Hegeman; Nauman Siddiqui; Amy Stella; Saurabh Rajguru; Kyleigh Twaroski; Luke Zurbriggen; Julie M. Jorns; Hallgeir Rui; Quinton J. Keigley; Scott B. Perlman; Kelley Salem; Tyler J. Bradshaw; Tarek Sahmoud; Kari Wisinski
